HBV X protein: elucidating a role in oncogenesis

Author： Feitelson Mark A Reis Helena MGPV Pan Jingbo Clayton Marcy Sun Bill Satiroglu-Tufan N Lale Lian Zhaorui

ISSN： 1746-0794

Source： Future Virology, Vol.3, Iss.5, 2008-09, pp. : 455-470

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies

Current Cancer Drug Targets, Vol. 15, Iss. 2, 2015-02 ,pp. : 145-157

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondria-associated HBV x antigen: what is going on?

By Feitelson Mark A Arzumanyan Alla

Future Virology, Vol. 4, Iss. 2, 2009-03 ,pp. : 127-131

Future Medicine

Access to resources Recommend Favorite

Role of tenofovir in the treatment of chronic HBV infection

By van Böömmel Florian Berg Thomas

Future Virology, Vol. 3, Iss. 3, 2008-05 ,pp. : 207-220

Future Medicine

Access to resources Recommend Favorite

Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease

By Kim Daniel Seung Marsillach Judit Furlong Clement E Jarvik Gail P

Pharmacogenomics, Vol. 14, Iss. 12, 2013-09 ,pp. : 1495-1515

Future Medicine

Access to resources Recommend Favorite

By Lim Lucy Tran Bang Manh Vincan Elizabeth Locarnini Stephen Warner Nadia

Future Virology, Vol. 7, Iss. 12, 2012-12 ,pp. : 1237-1249

Future Medicine

Access to resources Recommend Favorite